Tata Elxsi Q4 FY26 Revenue at ₹993.8 Cr, Up 4.2% QoQ; FY26 Revenue at ₹3,757.4 Cr
Tata Elxsi reported Q4 FY26 revenue of ₹993.8 Cr, a 4.2% QoQ increase, and FY26 revenue of ₹3,757.4 Cr. PBT margin for Q4 FY26 was 25.6%. Key wins include strategic partnerships with Mercedes-Benz and a multi-million USD deal for next-gen operator systems. The company also launched an Offshore Development Centre for Terumo.
The announcement details robust financial performance and significant new business wins across key verticals, which are material to the company's future growth and market position. The detailed financial metrics and strategic partnerships suggest a substantial impact on investor perception and company valuation.
The company reported strong revenue growth QoQ and YoY, along with healthy profit margins. Several significant deal wins and strategic partnerships across various sectors indicate positive business momentum.
Tata Elxsi Limited announced its financial results for the fourth quarter and full year ended March 31, 2026. For the fourth quarter of FY'26, the company reported operating revenue of ₹993.8 crores, marking a healthy 4.2% quarter-on-quarter (QoQ) growth. The PBT margin stood at 25.6% for the quarter. For the full fiscal year 2026, Tata Elxsi achieved a revenue of ₹3,757.4 crores with a PBT margin of 23.4%. The company also reported a 0.9% QoQ growth in revenue in constant currency (CC) terms, and 1.0% YoY growth in CC.
In Q4 FY26, EBITDA was reported at 24.6% and PBT at 25.6%. PBT stood at ₹267.8 crores, showing a 10.7% QoQ and 20.9% YoY growth. PAT was ₹220.4 crores, up 23.1% QoQ and 27.8% YoY. Segment-wise, Transportation revenue grew by 3.6% QoQ, Media and Communications revenue increased by 9.5% QoQ, while Healthcare revenue declined by 10.5% QoQ.
The company highlighted several strategic wins and partnerships during the year. These include being selected as a strategic partner by Mercedes-Benz for Vehicle Software Engineering and SDV development, winning a multi-million USD program for next-gen operator information and control systems from a US-based off-highway OEM, and a multi-year deal with a Japan-headquartered automotive OEM for advanced system design and simulation. In Media and Communications, Tata Elxsi was chosen by a leading EMEA broadcaster to develop a digital-first platform and by a Tier-1 CPE OEM as a strategic engineering partner. The Healthcare segment saw the launch of an Offshore Development Centre for Terumo to accelerate innovation in cardiac and vascular medical devices, and a multi-million, multi-year deal with a global MedTech leader for regulatory workflow transformation using Gen AI.
Manoj Raghavan, CEO and MD, expressed focus on scaling differentiated design-led and AI-enabled offerings, strengthening operational leverage, and driving sustainable growth and healthy margins in the upcoming financial year.
What to do with a filing like this
Tata Elxsi Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Tata Elxsi Limited. Read the original for the full detail.